Media coverage

NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics

May 11, 2022

    https://www.benzinga.com/markets/cannabis/22/05/27124788/exclusive-nasdaq-listed-enveric-to-split-into-two-companies-one-for-cannabinoids-one-for-psyched  

Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries [Benzinga]

April 19, 2022

https://www.benzinga.com/general/biotech/22/04/26693851/exclusive-enveric-offers-investors-rare-exposure-to-both-cannabis-and-psychedelic-industries

Bob Dagher, Chief Medical Officer at Enveric Biosciences [The Green Rush]

March 31, 2022

Inside the Race to Make Psychedelics ‘Mainstream Medicines’ [Endpoints News]

March 29, 2022

https://endpts.com/inside-the-race-to-make-psychedelics-mainstream-medicines/

Five Companies Developing Second Generation Psychedelics For Mental Health [Benzinga]

March 24, 2022

https://www.benzinga.com/markets/cannabis/22/03/26284541/five-companies-developing-second-generation-psychedelics-for-mental-health

Groundbreaking Trial to Explore Psychedelic Therapy for Cancer Distress [Psychedelic Health]

February 21, 2022

Groundbreaking trial to explore psychedelic therapy for cancer distress

Psilocybin For Cancer Related Distress: Enveric To Launch Clinical Trial In Partnership With University of Calgary [via Benzinga]

February 17, 2022

https://www.benzinga.com/markets/cannabis/22/02/25697576/psilocybin-for-cancer-related-distress-enveric-to-launch-clinical-trial-in-partnership-with-univ

UCalgary to Collaborate on Clinical Trial Assessing Psychedelic Treatments and Cancer Related Distress [The Edmonton Journal]

February 17, 2022

https://edmontonjournal.com/cannabis-health/ucalgary-to-collaborate-on-clinical-trial-assessing-psychedelic-treatments-and-cancer-related-distress

Enveric Biosciences Files Provisional Patent for Cannabinoid + Celecoxib Conjugate EV104 after Successful Synthesis [IPO Edge]

February 8, 2022

https://finance.yahoo.com/news/enveric-biosciences-files-provisional-patent-214536823.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZW52ZXJpYy5jb20v&guce_referrer_sig=AQAAAIp7hCuGPXC1J-RCbbPJx9NsQx6Vv_FJkaRKGgsvfN6gOH4gXdA-Asvck2OuCViP4Xuk_XgLTMWBu2e4cKprhWS4Yo9pSGsXuXEBVV9JhnthUovjabluWHepMDqRGj14_EPIjnoXICNk8rB_uf_w13TzI_r9DobeVVdjBEjOFbD6

Cannabis For Arthritis: Enveric Biosciences Files Patent On CBD Medication For Osteoarthritis [Benzinga]

February 8, 2022

https://www.benzinga.com/general/biotech/22/02/25476247/cannabis-for-arthritis-enveric-biosciences-files-patent-on-cbd-medication-for-osteoarthritis